中国最顶尖的芬太尼制造者否认美国有毒品危机,尽管美国指责美国有国家关联的先质出口。 China’s top fentanyl maker denies enabling U.S. drug crisis, despite U.S. accusations of state-linked precursor exports.

NBC News访问中国最大的芬太尼生产商Yichang Humanwell制药公司, 在一个拥有自动化、无菌流程和严格规程的高度戒备设施内。 NBC News visited Yichang Humanwell Pharmaceutical, China’s largest fentanyl producer, in a high-security facility with automated, sterile processes and strict protocols. 该公司拥有五家在中国制造药物芬太尼的执照, 该公司称51年来从未失去过剂量, 仅供货医院, 而不是美国、墨西哥或加拿大。 The company, one of five licensed to make medical fentanyl in China, says it has never lost a dose in 51 years and only supplies hospitals, not the U.S., Mexico, or Canada. 尽管中国于2019年禁止非医疗芬太尼, 但美国官员仍指控与中国国家有联系的实体通过税收退税等奖励措施, 准许非法前体出口。 Despite China’s 2019 ban on non-medical fentanyl, U.S. officials accuse Chinese state-linked entities of enabling illicit precursor exports through incentives like tax rebates. 中国否认错失行为,指责美国的需求,并坚持其药物管制是世界上最严格的。 China denies wrongdoing, blaming American demand and asserting its drug controls are the strictest in the world. 芬太尼仍然是一个主要的外交问题,特朗普总统准备在与习近平主席的会谈中提出这个问题。 Fentanyl remains a major diplomatic issue, with President Trump set to raise it in talks with President Xi Jinping.